Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD)
Status:
Completed
Trial end date:
2019-06-12
Target enrollment:
Participant gender:
Summary
The overall goal of the proposed project is to improve the treatment of individuals with AUD.
The investigators will conduct the first pilot human laboratory study to assess the effects
of two doses of lacosamide on alcohol drinking and craving. The investigators will assess its
effects on reducing alcohol intake using a human laboratory method, the Yale Alcohol Drinking
Paradigm (ADP). The investigators will also assess the feasibility of the Alcohol Drinking
Paradigm (ADP) in order to position our research team to have the capacity to conduct future,
larger, hypothesis-testing human laboratory-based experiments designed to test the efficacy
of potential alcohol treatments.